Showing all 20 results
Cat# | Name | Structure | M.W. | Purity | Pricing | |
---|---|---|---|---|---|---|
Antibody | ||||||
AP15520 | Inotuzumab | ≥95% | Pricing | |||
AP15501 | Trastuzumab | ≥99.8 | Pricing | |||
AP15504 | Enfortumab | ≥99% | Pricing | |||
AP15502 | Sacituzumab | ≥99% | Pricing | |||
AP15519 | Pivekimab | ≥95% | Pricing | |||
AP15518 | Vobramitamab | ≥99% | Pricing | |||
AP15517 | Disitamab | ≥95% | Pricing | |||
AP15516 | Mirzotamab | ≥95% | Pricing | |||
AP15515 | Upifitamab | ≥98% | Pricing | |||
AP15514 | Tisotumab | ≥95% | Pricing | |||
AP15513 | Polatuzumab | 145260 | ≥98% | Pricing | ||
AP15512 | Brentuximab | ≥98% | Pricing | |||
AP15510 | Glembatumumab | ≥99% | Pricing | |||
AP15509 | Belantamab | ≥99% | Pricing | |||
AP15508 | Gemtuzumab | ≥95% | Pricing | |||
AP15506 | Inebilizumab | ≥99% | Pricing | |||
AP15505 | Datopotamab | ≥98% | Pricing | |||
AP15503 | Daratumumab | ≥95% | Pricing |